OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
KYCO54

Keya Cosmetics Ltd

Personal ProductsVerified

Keya Cosmetics Ltd has a debt-to-equity ratio of 1.07, indicating a moderate level of leverage, and a current ratio of 4.39, suggesting strong short-term liquidity. The company's return on equity of 3.84% is a measure of its profitability relative to shareholders' equity. The company's profitability is reflected in its net income of 445,786,160 BDT, with an operating income of 707,251,430 BDT. These figures suggest a healthy margin, although a direct comparison to industry benchmarks is necessary to fully assess performance. Keya Cosmetics Ltd's revenue is concentrated in the personal products segment, with no disclosed geographic diversification. This concentration may pose a risk if market conditions in the primary operating region change. The company's growth trajectory is positive, with a net income increase from previous periods. However, the exact growth rate and future projections are not provided in the available data. The risk assessment indicates a medium liquidity risk and a low dilution risk. The company's net cash position is negative after accounting for total debt, which could affect its financial flexibility. Recent events and filings have not been disclosed in the available data, so the impact of any recent developments on the company's financial position is unknown.

30-day price · KYCO(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyKeya Cosmetics Ltd
TickerKYCO.DH
SectorConsumer Non-Cyclicals
BusinessPersonal & Household Products & Services
Industry groupPersonal & Household Products & Services
IndustryPersonal Products
AI analysis

Business. Keya Cosmetics Ltd is a personal products company that generates revenue primarily through the sale of cosmetics and related personal care items.

Classification. Keya Cosmetics Ltd is classified under the Consumer Non-Cyclicals economic sector, Personal & Household Products & Services business sector, and Personal Products industry with a confidence level of 0.92.

Keya Cosmetics Ltd has a debt-to-equity ratio of 1.07, indicating a moderate level of leverage, and a current ratio of 4.39, suggesting strong short-term liquidity. The company's return on equity of 3.84% is a measure of its profitability relative to shareholders' equity. The company's profitability is reflected in its net income of 445,786,160 BDT, with an operating income of 707,251,430 BDT. These figures suggest a healthy margin, although a direct comparison to industry benchmarks is necessary to fully assess performance. Keya Cosmetics Ltd's revenue is concentrated in the personal products segment, with no disclosed geographic diversification. This concentration may pose a risk if market conditions in the primary operating region change. The company's growth trajectory is positive, with a net income increase from previous periods. However, the exact growth rate and future projections are not provided in the available data. The risk assessment indicates a medium liquidity risk and a low dilution risk. The company's net cash position is negative after accounting for total debt, which could affect its financial flexibility. Recent events and filings have not been disclosed in the available data, so the impact of any recent developments on the company's financial position is unknown.
Key takeaways
  • Keya Cosmetics Ltd has a strong current ratio of 4.39, indicating good short-term liquidity.
  • The company's debt-to-equity ratio of 1.07 suggests a moderate level of financial leverage.
  • A return on equity of 3.84% indicates the company is generating a modest return for its shareholders.
  • The company's profitability is reflected in its net income of 445,786,160 BDT.
  • The risk assessment highlights a medium liquidity risk and a low dilution risk.
  • # RATIONALES
  • {
  • "margin_outlook_rationale": "The company's operating income of 707,251,430 BDT suggests a healthy margin, but the exact outlook is not provided in the available data.",
Financial snapshot
PeriodHA-latest
CurrencyBDT
Revenue$2.72B
Gross profit$797.7M
Operating income$707.3M
Net income$445.8M
R&D
SG&A
D&A
SBC
Operating cash flow$126.8M
CapEx-$4.3M
Free cash flow
Total assets
Total liabilities$13.19B
Total equity$11.60B
Cash & equivalents
Long-term debt$12.42B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$9.27B$2.01B$1.33B
FY-3$10.41B$2.64B$1.68B
FY-2$10.58B$2.68B$1.21B
FY-1$10.41B-$11.88B-$12.97B-$12.62B
FY0$9.01B$1.52B$236.4M$537.3M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$24.50B$11.16B
FY-3$28.64B$12.83B
FY-2$31.95B$14.05B
FY-1$26.09B$18.7M
FY0$27.22B$255.0M
PeriodOCFCapExFCFSBC
FY-4-$337.9M-$29.0M
FY-3-$2.41B-$10.5M
FY-2-$2.05B-$2.4M
FY-1-$978.3M-$12.4M-$12.62B
FY0-$714.9M-$27.0M$537.3M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$2.72B$707.3M$445.8M
FQ-6$2.38B$624.3M$407.1M
FQ-5$2.41B$644.6M$395.6M
FQ-4$2.90B$660.4M$426.6M
FQ-3$2.97B$817.6M$548.2M
FQ-2$2.50B$653.1M$294.4M
FQ-1$2.80B$666.7M$270.0M
FQ0$2.31B$538.4M$99.3M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$11.60B
FQ-6$12.01B
FQ-5$26.93B$12.41B
FQ-4$28.64B$12.83B
FQ-3$30.00B$13.38B
FQ-2$30.95B$13.68B
FQ-1$31.73B$13.95B
FQ0$31.95B$14.05B
PeriodOCFCapExFCFSBC
FQ-7$126.8M-$4.3M
FQ-6-$637.7M-$5.6M
FQ-5-$1.07B-$5.6M
FQ-4-$2.41B-$10.5M
FQ-3-$755.0M
FQ-2-$1.42B
FQ-1-$1.89B
FQ0-$2.05B-$2.4M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash-$12.42B
Current ratio4.4
Debt/Equity1.1
ROA
ROE3.8%
Cash conversion28.0%
CapEx/Revenue-0.2%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Personal Products · cohort 185 companies
MetricKYCOActivity
Op margin26.0%6.0% medp25 0.5% · p75 12.6%top quartile
Net margin16.4%5.2% medp25 0.5% · p75 10.9%top quartile
Gross margin29.3%43.2% medp25 26.0% · p75 61.0%below median
R&D / revenue1.8% medp25 1.8% · p75 1.8%
CapEx / revenue-0.2%-3.0% medp25 -5.5% · p75 -1.3%top quartile
Debt / equity107.0%13.3% medp25 2.5% · p75 55.2%top quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-12 00:48 UTC#b51c5ebe
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 09:21 UTCJob: 003ebec4